0001127602-18-019981.txt : 20180605
0001127602-18-019981.hdr.sgml : 20180605
20180605150759
ACCESSION NUMBER: 0001127602-18-019981
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180601
FILED AS OF DATE: 20180605
DATE AS OF CHANGE: 20180605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheridan William P
CENTRAL INDEX KEY: 0001439174
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 18880892
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-06-01
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001439174
Sheridan William P
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP - CMO
Common Stock
2018-06-01
4
M
0
42112
2.58
A
63170
D
Common Stock
2018-06-01
4
S
0
42112
6.30
D
21058
D
Emp. Stock Option (Right to Buy)
2.58
2018-06-01
4
M
0
42112
0
D
2009-07-01
2018-07-01
Common Stock
42112
0
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2017 and due to the upcoming expiry of the option.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.23 to $6.46. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Alane P. Barnes, by power of attorney
2018-06-05